Vitamin D status has been negatively associated with the presence of type II DM and glycemic control. However, a cause-effect relationship between vitamin D deficiency and glycemic control has not been established. The investigators plan to conduct a double blind, randomized, placebo controlled trial on the effect of vitamin D supplementation on glycemic control in Type II DM.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
25
vitamin D3 2000 IU orally, daily for 6 months
vitamin D3 5000 IU orally, daily for 6 months
placebo orally, daily for six months
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
Area under the curve of HA1C.
Time frame: 6 months
Area under the curve for BP
Time frame: 6 months
area under the curve of weight
Time frame: 6 months
area under the curve for 25 OH vitamin D level
Time frame: 6 months
area under the curve of fasting blood glucose
Time frame: 6 months
area under the curve of 2 hour post breakfast glucose
Time frame: 6 months
fasting insulin to glucose ratio
Time frame: 6 months
incidence of hypercalcemia
Time frame: 6 months
incidence of hypercalciuria
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.